Clinical Trial Update: Dual Treatment With Lithium and Valproate in ALS. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dual therapy with lithium and valproate in amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Amyotrophic Lateral Sclerosis Sporadic

Drugs mentioned

• Lithium (Lithium carbonate)
• Valproate (valproate)

Snippet

Sponsor: El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez | Conditions: Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis, Sporadic | Phase 2 | Status: COMPLETED